|
Delayed onset renal failure in a patient on tenofovir based antiretroviral regimen
M Murali Krishna1, M. V. S. Subbalaxmi1, Megha Uppin2, S Radhika3
1 Department of General Medicine, Nizam's Institute of Medical Sciences, Hyderabad, Andhra Pradesh, India
2 Department of Pathology, Nizam's Institute of Medical Sciences, Hyderabad, Andhra Pradesh, India
3 Department of Clinical Pharmacology and Theurapeutics, Nizam's Institute of Medical Sciences, Hyderabad, Andhra Pradesh, India
Correspondence Address:
M. V. S. Subbalaxmi
Department of General Medicine, Nizam«SQ»s Institute of Medical Sciences, Hyderabad, Andhra Pradesh
India
Tenofovir is recommended as one of the first line agents in combination with other antiretroviral drugs for management of human immunodeficiency virus (HIV). It is known to cause renal failure after exposure for a median duration of 5 months. We report tenofovir induced adverse drug reaction in a 56-year-old female patient who was diagnosed to have HIV 1 infection since 10 years. The combination antiretroviral treatment included tenofovir, emtricitabine and ritonavir/lopinavir regimen since the last 6 years. She presented with recent onset renal failure and renal biopsy showed interstitial nephritis which could probably attributable to tenofovir.
How to cite this article:
Krishna M M, Subbalaxmi M, Uppin M, Radhika S. Delayed onset renal failure in a patient on tenofovir based antiretroviral regimen.Indian J Pharmacol 2014;46:230-231
|
How to cite this URL:
Krishna M M, Subbalaxmi M, Uppin M, Radhika S. Delayed onset renal failure in a patient on tenofovir based antiretroviral regimen. Indian J Pharmacol [serial online] 2014 [cited 2023 Sep 28 ];46:230-231
Available from: https://www.ijp-online.com/article.asp?issn=0253-7613;year=2014;volume=46;issue=2;spage=230;epage=231;aulast=Krishna;type=0 |
|
